ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 4 filers reported holding ENCOMPASS HEALTH CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $441,443 | +0.8% | 6,573 | +1.6% | 0.00% | 0.0% |
Q2 2023 | $438,151 | +51.9% | 6,471 | +21.4% | 0.00% | 0.0% |
Q1 2023 | $288,461 | +1.7% | 5,332 | +12.5% | 0.00% | 0.0% |
Q4 2022 | $283,559 | -15.9% | 4,741 | -36.4% | 0.00% | 0.0% |
Q3 2022 | $337,000 | -33.1% | 7,455 | -17.1% | 0.00% | 0.0% |
Q2 2022 | $504,000 | -11.4% | 8,996 | +12.4% | 0.00% | 0.0% |
Q1 2022 | $569,000 | +9.0% | 8,001 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $522,000 | -3.2% | 8,001 | +11.3% | 0.00% | 0.0% |
Q3 2021 | $539,000 | -21.9% | 7,189 | -16.3% | 0.00% | 0.0% |
Q2 2021 | $690,000 | -8.0% | 8,589 | -5.3% | 0.00% | -50.0% |
Q1 2021 | $750,000 | -8.1% | 9,070 | -8.1% | 0.00% | 0.0% |
Q4 2020 | $816,000 | +15.6% | 9,868 | -9.2% | 0.00% | 0.0% |
Q3 2020 | $706,000 | +25.6% | 10,868 | +19.9% | 0.00% | +100.0% |
Q2 2020 | $562,000 | -7.3% | 9,068 | -4.2% | 0.00% | -50.0% |
Q1 2020 | $606,000 | -7.6% | 9,468 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $656,000 | +9.5% | 9,468 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $599,000 | – | 9,468 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 396,670 | $27,477,000 | 7.28% |
Endurant Capital Management LP | 163,092 | $11,297,000 | 3.56% |
REINHART PARTNERS, LLC. | 656,158 | $45,452,000 | 3.34% |
RK Capital | 117,590 | $8,145,000 | 3.05% |
HIGH POINTE CAPITAL MANAGEMENT LLC | 27,150 | $1,881,000 | 2.23% |
Wolf Group Capital Advisors | 47,461 | $3,288,000 | 2.16% |
Copeland Capital Management, LLC | 631,346 | $43,734,000 | 1.92% |
Advantage Alpha Capital Partners LP | 100,722 | $6,977,000 | 1.88% |
Rock Springs Capital Management LP | 815,000 | $56,455,000 | 1.78% |
Kalos Management, Inc. | 61,180 | $4,237,000 | 1.54% |